Mankind Pharma (MANKIND.NS) Financial Analysis & Valuation | Quarter Chart
Mankind Pharma (MANKIND.NS)
MANKIND.NSPrice: $26.99
Fair Value: 🔒
🔒score
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, an... more
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer ... more
Description
Shares
| Market Cap | $11.15B | Exchange | NSE |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | IN | CEO | Sheetal Arora |
| IPO Date | 2023-05-09 | CAGR | 0.16% |
| Employees | 19,540 | Website | www.mankindpharma.com |
| Div. Yield | 0.04% | Payout Ratio | 0.02% |
| Buy Back Yield | — | Total Yield | 0.04% |
MANKIND.NS chart loading...
Fundamentals
Technicals
| Enterprise Value | $886.25B | P/E Ratio | 51.73 |
| Forward P/E | 34.67 | PEG Ratio | 1.69 |
| P/S Ratio | 7.81 | P/B Ratio | 6.82 |
| P/CF Ratio | 68.01 | P/FCF Ratio | 81.57 |
| EPS | $0.52 | EPS Growth 1Y | -6.28% |
| EPS Growth 3Y | 44.63% | EPS Growth 5Y | — |
| Revenue Growth 1Y | 17.65% | Gross Margin | 0.57% |
| Operating Margin | 0.19% | Profit Margin | 0.13% |
| ROE | 0.13% | ROA | 0.07% |
| ROCE | 0.13% | Current Ratio | 1.07 |
| Quick Ratio | 0.74 | Cash Ratio | 0.07 |
| Debt/Equity | 0.39 | Interest Coverage | 4.27 |
| Altman Z Score | 6.15 | Piotroski Score | 3 |